PRESS RELEASE : CompuGroup Medical expects revenues of EUR 1 billion in 2021 and invests in growth acceleration

 
 DGAP-News: CompuGroup Medical SE & Co. KGaA / Key word(s): 
Miscellaneous/Development of Sales 
CompuGroup Medical expects revenues of EUR 1 billion in 2021 and invests in 
growth acceleration 
 
2020-12-07 / 18:56 
The issuer is solely responsible for the content of this announcement. 
 
· *CompuGroup Medical is planning for an approximately 20 % increase in 
revenue for 2021* 
 
· *Moderate adjusted EBITDA development expected for 2021* 
 
· *Organic growth is being accelerated* 
 
· *Significant increase in investment in new technologies and distribution 
capabilities to benefit from the rapidly growing trend towards 
digitization in the healthcare sector* 
 
· *Confirmation of 2020 guidance which had been raised in August* 
 
Koblenz. Today, CompuGroup Medical Management SE's Administrative Board 
resolved the budget plans for the financial year 2021. The Joint Committee 
of CompuGroup Medical SE & Co. KGaA will discuss this on December 14, 2020. 
 
For the financial year 2021 very strong revenue growth of around 20 % is 
expected. This includes the two significant acquisitions in 2020, the 
acquisition of parts of the German and Spanish hospital information systems 
from Cerner, which was closed in July 2020, as well as the acquisition of US 
eMDs, Inc., which was announced on November 23, 2020. Effects for the 
Hospital Information Systems segment will occur mostly in Germany, and for 
the Ambulatory Information Systems business segment in the USA, with the US 
transaction still being subject to regulatory approvals. The strong revenue 
growth will also be driven by significantly higher organic growth of more 
than +5 % in the 2021 fiscal year. 
 
Adjusted EBITDA for the financial year 2021 is expected to remain at a 
similar level as in 2020. This corresponds to an EBITDA margin in a range of 
20 to 23 %. The reduction in operating margin is attributable to planned 
additional investments in new technologies and distribution to realize 
numerous growth opportunities arising for CGM from the fast progressing 
digitization of the healthcare system. The Managing Directors and the 
Administrative Board want to use these opportunities to enable strong 
organic growth and an attractive EBITDA margin also in the years following. 
As planned, the full guidance for the financial year 2021 will be published 
in the standard format on February 4, 2021. 
 
CompuGroup Medical also confirms the guidance for the financial year 2020 
which was raised in August. For the current year 2020, CompuGroup Medical is 
still expecting a revenue increase to a range of EUR 820 million to EUR 860 
million and an adjusted EBITDA between EUR 205 million and EUR 220 million. 
 
Frank Gotthardt, founder and CEO, said, "The rapidly progressing 
digitization in the healthcare sector is a blessing for humanity. This 
offers us great business opportunities and at the same time obliges us to 
seize them for the benefit of our customers, our employees and our 
shareholders. I am excited about the great growth opportunities for CGM. And 
I am delighted with the enthusiasm, skill and drive of our team in tackling 
the enormous challenges that lie ahead. I could not wish for a better 
setting to hand the leadership of this successful team over to Dr. Dirk 
Wössner and his colleagues on the Executive Board at the end of the year." 
 
Explanations of the alternative financial ratios used (Alternative 
Performance Measures (APM)) can be found on the website of CompuGroup 
Medical SE & Co. KGaA in the annual report of CompuGroup Medical SE & Co. 
KGaA on pages 28 and 44 here [1]. 
 
*About CompuGroup Medical SE & Co. KGaA* 
CompuGroup Medical is one of the leading eHealth companies in the world. 
With a revenue base of EUR 746 million in 2019, its software products are 
designed to support all medical and organizational activities in doctors' 
offices, pharmacies, laboratories and hospitals. Its information services 
for all parties involved in the healthcare system and its web-based personal 
health records contribute towards safer and more efficient healthcare. 
CompuGroup Medical's services are based on a unique customer base of more 
than 1.5 million users, including doctors, dentists, pharmacists and other 
health professionals in inpatient and outpatient facilities. With locations 
in 18 countries and products in 56 countries worldwide, CompuGroup Medical 
is the eHealth company with one of the highest coverages among eHealth 
service providers. Approximately 6,300 highly qualified employees support 
customers with innovative solutions for the steadily growing demands of the 
healthcare system. 
 
*Contact for media representatives:* 
Michael Franz 
Head of Brand Communication 
P [phone] 
F [phone] 
E-mail: [e-mail] 
 
*Contact for analysts and investors:* 
Claudia Thomé 
Head of Investor Relations 
P [phone] 
F [phone] 
E-mail: [e-mail] 
 
2020-12-07 Dissemination of a Corporate News, transmitted by DGAP - a 
service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
 
The DGAP Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
Language:    English 
Company:     CompuGroup Medical SE & Co. KGaA 
             Maria Trost 21 
             56070 Koblenz 
             Germany 
Phone:       [phone] 
Fax:         [phone] 
E-mail:      [e-mail] 
Internet:    www.cgm.com 
ISIN:        DE000A288904 
WKN:         A28890 
Indices:     MDAX, TecDAX 
Listed:      Regulated Market in Frankfurt (Prime Standard); Regulated 
             Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, 
             Stuttgart, Tradegate Exchange 
EQS News ID: 1153388 
 
End of News DGAP News Service 
 
1153388 2020-12-07 
 
 
1: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=98ac6d6b21205622ed42dee86bd8c29f&application_id=1153388&site_id=vwd&application_name=news

(END) Dow Jones Newswires

December 07, 2020 12:56 ET (17:56 GMT)